Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Bone Metastases
Interventions: DRUG: Dasatinib|DRUG: Zoledronic Acid
Sponsor: M.D. Anderson Cancer Center
Collaborators: Bristol-Myers Squibb